LIMD1
LIM domain-containing protein 1
Also known as: LIMD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UGP4
- Gene
- LIMD1
- Ensembl
- ENSG00000144791
- Chromosome
- 3
- Canonical length
- 676 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Focal adhesion sites
OverviewNCBI Gene
Predicted to enable transcription corepressor activity. Involved in several processes, including negative regulation of hippo signaling; negative regulation of macromolecule biosynthetic process; and response to hypoxia. Acts upstream of or within P-body assembly and miRNA-mediated post-transcriptional gene silencing. Located in several cellular components, including P-body; adherens junction; and focal adhesion. Part of RISC complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
676 residues, UniProt reviewed canonical sequence.
>Q9UGP4|LIMD1
1 MDKYDDLGLE ASKFIEDLNM YEASKDGLFR VDKGAGNNPE FEETRRVFAT KMAKIHLQQQ
61 QQQLLQEETL PRGSRGPVNG GGRLGPQARW EVVGSKLTVD GAAKPPLAAS TGAPGAVTTL
121 AAGQPPYPPQ EQRSRPYLHG TRHGSQDCGS RESLATSEMS AFHQPGPCED PSCLTHGDYY
181 DNLSLASPKW GDKPGVSPSI GLSVGSGWPS SPGSDPPLPK PCGDHPLNHR QLSLSSSRSS
241 EGSLGGQNSG IGGRSSEKPT GLWSTASSQR VSPGLPSPNL ENGAPAVGPV QPRTPSVSAP
301 LALSCPRQGG LPRSNSGLGG EVSGVMSKPN VDPQPWFQDG PKSYLSSSAP SSSPAGLDGS
361 QQGAVPGLGP KPGCTDLGTG PKLSPTSLVH PVMSTLPELS CKEGPLGWSS DGSLGSVLLD
421 SPSSPRVRLP CQPLVPGPEL RPSAAELKLE ALTQRLEREM DAHPKADYFG ACVKCSKGVF
481 GAGQACQAMG NLYHDTCFTC AACSRKLRGK AFYFVNGKVF CEEDFLYSGF QQSADRCFLC
541 GHLIMDMILQ ALGKSYHPGC FRCVICNECL DGVPFTVDSE NKIYCVRDYH KVLAPKCAAC
601 GLPILPPEGS DETIRVVSMD RDYHVECYHC EDCGLELNDE DGHRCYPLED HLFCHSCHVK
661 RLEKRPSSTA LHQHHFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LIMD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- lung: 16 nTPM
- skeletal muscle: 14 nTPM
- thyroid gland: 11 nTPM
- spleen: 10 nTPM
- lymph node: 9.7 nTPM
- pancreas: 9.4 nTPM
Single-cell type
- alveolar cells type 1: 219 nCPM
- tuft cells: 185 nCPM
- transitional alveolar cells: 179 nCPM
- oligodendrocyte progenitor cells: 144 nCPM
- pdcs: 130 nCPM
- retinal pigment epithelial cells: 119 nCPM
Immune cell
- plasmacytoid DC: 5.7 nTPM
- naive B-cell: 4 nTPM
- non-classical monocyte: 4 nTPM
- basophil: 3.8 nTPM
- memory B-cell: 2.3 nTPM
- intermediate monocyte: 2 nTPM
Brain region
- choroid plexus: 27 nTPM
- medulla oblongata: 24 nTPM
- white matter: 22 nTPM
- thalamus: 21 nTPM
- pons: 21 nTPM
- midbrain: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.42
- gnomAD missense Z
- 0.48
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell migration
- cytoskeleton organization
- miRNA-mediated gene silencing by inhibition of translation
- miRNA-mediated post-transcriptional gene silencing
- negative regulation of canonical Wnt signaling pathway
- negative regulation of DNA-templated transcription
- negative regulation of hippo signaling
- negative regulation of osteoblast differentiation
- osteoblast development
- P-body assembly
- phosphorylation
- regulation of cell shape
- regulation of DNA-templated transcription
- response to hypoxia
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LIMD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LIMD1 as an antibody target. Whether an autoantibody or antibody against LIMD1 could matter depends on whether native LIMD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LIMD1 is annotated at the cell surface, where native LIMD1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LIMD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...